Published in Health Insurance Week, September 3rd, 2006
U.S. sales in the second quarter of 2006 increased 19% over the second quarter of 2005 to $231 million. According to IMS data in the U.S., Copaxone reached a market share of 33.9% in TRx and 34.9% in NRx in June 2006.
Outside the U.S., mainly in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.